Showing results (181-190 of 299) with videos related to
Sort By:
Pageof 30
The Journal of Antimicrobial Chemotherapy|April 20, 2013
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapyBabafemi Taiwo, Roy M Matining, Lu Zheng, et al.AIDS (London, England)|December 15, 2010
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical careHeidi M Crane, Carl Grunfeld, James H Willig, et al.Journal of Virus Eradication|February 26, 2019
Stability of plasma indices of inflammation/coagulation and homeostasis after fatty and non-fatty meals in treated people with HIVDominic Dorazio, Douglas W Kitch, Netanya S Utay, et al.Pathogens & Immunity|July 25, 2017
Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS TrialPablo F Belaunzarán-Zamudio, Livio Azzoni, David H Canaday, et al.The Journal of Infectious Diseases|June 23, 2010
Intracellular Casp8p41 content is inversely associated with CD4 T cell countNathan W Cummins, Wei Jiang, John McGinty, et al.The Journal of Infectious Diseases|May 6, 2014
Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentAllan R Tenorio, Yu Zheng, Ronald J Bosch, et al.Journal of Virology|November 27, 2004
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infectionMaureen P Martin, Michael M Lederman, Holli B Hutcheson, et al.Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.Open Forum Infectious Diseases|February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral TherapyThomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.AIDS (London, England)|September 28, 2002
Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced diseaseHernan Valdez, Elizabeth Connick, Kimberly Y Smith, et al.Pageof 30